CD123-CD16-NK Cells Immunotherapy for AML

Clinical trial NCT06835140 · RECRUITING

Trial details

NCT number: NCT06835140
Sponsor: Chunji Gao
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

AML (Acute Myelogenous Leukemia)NK Cell CD123+ Acute Myeloid Leukemia

Start date: 2025-02-21
Primary completion: 2025-12-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.